We are live on ! Find out more
SHI

SV Health Investors Portfolio holdings

AUM $32.3M
1-Year Est. Return 20.15%
This Fund
S&P 500
This Quarter Est. Return
-23.19%
1 Year Est. Return
-20.15%
3 Year Est. Return
+97.4%
5 Year Est. Return
+328.26%
10 Year Est. Return
–
AUM
$82.8M
AUM Growth
-$71.9M
Cap. Flow
-$40.1M
Cap. Flow %
-48.46%
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
3
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
STRO icon
Sutro Biopharma
STRO
+$27.1M
2
AHCO icon
AdaptHealth
AHCO
+$11.7M
3
BVS icon
Bioventus
BVS
+$1.24M
4
BCYC
Bicycle Therapeutics
BCYC
+$43.7K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCYC
1
Bicycle Therapeutics
BCYC
$303M
$40.2M 48.61%
917,218
-936
-0.1% -$43.7K
BVS icon
2
Bioventus
BVS
$942M
$21M 25.35%
1,488,596
-92,435
-6% -$1.24M
AHCO icon
3
AdaptHealth
AHCO
$774M
$20.7M 24.99%
1,290,978
-650,140
-33% -$11.7M
XFOR icon
4
X4 Pharmaceuticals
XFOR
$419M
$545K 0.66%
10,383
– –
ASXC
5
DELISTED
Asensus Surgical, Inc.
ASXC
$319K 0.39%
510,142
– –
STRO icon
6
Sutro Biopharma
STRO
$353M
– –
-182,454
Closed -$27.1M

Similar funds

SAM
Serengeti Asset Management New York $31.8M AUM 23.16% 1-Year Est. Return
FCOMV
Foresite Capital Opportunity Management V Larkspur, California $33.3M AUM 47.04% 1-Year Est. Return
LUGPSI
Lightspeed Ultimate General Partner Select III Menlo Park, California $31M AUM 76.89% 1-Year Est. Return
VCA
VIEX Capital Advisors Sunny Isles Beach, Florida $30.9M AUM 55.48% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
ACM
Afton Capital Management Charlotte, North Carolina $30.6M AUM 56.8% 1-Year Est. Return
KCM
Kingstown Capital Management New York $30.4M AUM 3.71% 1-Year Est. Return
KXA
KPCB XV Associates Menlo Park, California $35.8M AUM 57.59% 1-Year Est. Return

SV Health Investors's Q1 2022 Portfolio in Review

As of Q1 2022, SV Health Investors held 6 positions worth $82.8M, down 46% from $155M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

SV Health Investors withdrew a net $40.1M in Q1 2022, closing 1 position and reducing 3 holdings. Its most notable exit was Sutro Biopharma, an estimated $27.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • SV Health Investors's biggest Q1 2022 reduction was AdaptHealth, cutting an estimated $11.7M.
  • SV Health Investors fully exited Sutro Biopharma in Q1 2022, selling an estimated $27.1M.
  • SV Health Investors's ten largest holdings make up 100% of its $82.8M portfolio in Q1 2022.
  • SV Health Investors opened 0 new positions and closed 1 in Q1 2022.
  • SV Health Investors's portfolio value fell 46% quarter-over-quarter to $82.8M.

Based on SV Health Investors's 13F filing for Q1 2022, filed 16 May 2022.